Thor Halfdanarson, Professor of Oncology at Mayo Clinic School of Medicine, shared on X:
“Impact of therapy on quality of life in patients with NETs. Not surprisingly, SSAs and PRRT/RLT has a positive impact, especially among those with a functional syndrome. Targeted therapy (MKIs/mTORi) less so which is not surprising.
Depression common…”
Title: Impact of treatment on quality of life in neuroendocrine neoplasm survivors
Authors: Roberta Modica, Elio Benevento, Anna La Salvia, Rossella Mazzilli, Carla Pandozzi, Giulia Pecora, Luigi Barrea, Annamaria Colao, Antongiulio Faggiano
Read The Full Article at Endocrine-Related Cancer.
More posts featuring Thorvardur Halfdanarson.